117 related articles for article (PubMed ID: 24582150)
1. Metabolic profiling study of early and late recurrence of hepatocellular carcinoma based on liquid chromatography-mass spectrometry.
Zhou L; Liao Y; Yin P; Zeng Z; Li J; Lu X; Zheng L; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():163-70. PubMed ID: 24582150
[TBL] [Abstract][Full Text] [Related]
2. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
[TBL] [Abstract][Full Text] [Related]
3. Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometry.
Zhou L; Ding L; Yin P; Lu X; Wang X; Niu J; Gao P; Xu G
J Proteome Res; 2012 Nov; 11(11):5433-42. PubMed ID: 22946841
[TBL] [Abstract][Full Text] [Related]
4. Analysis of urinary metabolic signatures of early hepatocellular carcinoma recurrence after surgical removal using gas chromatography-mass spectrometry.
Ye G; Zhu B; Yao Z; Yin P; Lu X; Kong H; Fan F; Jiao B; Xu G
J Proteome Res; 2012 Aug; 11(8):4361-72. PubMed ID: 22768978
[TBL] [Abstract][Full Text] [Related]
5. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
[TBL] [Abstract][Full Text] [Related]
6. A modified k-TSP algorithm and its application in LC-MS-based metabolomics study of hepatocellular carcinoma and chronic liver diseases.
Lin X; Gao J; Zhou L; Yin P; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():100-8. PubMed ID: 24939728
[TBL] [Abstract][Full Text] [Related]
7. Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma.
Zhou C; Zhou HJ; Zhang XF; Lou LL; Ye QH; Zheng Y; Wang J; Zhu HT; Dong QZ; Jia HL; Zhu WW; Guo L; Zhao Y; Gao DM; Qin LX
Ann Surg Oncol; 2013 Mar; 20(3):929-37. PubMed ID: 23203407
[TBL] [Abstract][Full Text] [Related]
8. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics.
Huang Q; Tan Y; Yin P; Ye G; Gao P; Lu X; Wang H; Xu G
Cancer Res; 2013 Aug; 73(16):4992-5002. PubMed ID: 23824744
[TBL] [Abstract][Full Text] [Related]
9. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R
Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807
[TBL] [Abstract][Full Text] [Related]
10. Development of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery.
Shao Y; Zhu B; Zheng R; Zhao X; Yin P; Lu X; Jiao B; Xu G; Yao Z
J Proteome Res; 2015 Feb; 14(2):906-16. PubMed ID: 25483141
[TBL] [Abstract][Full Text] [Related]
11. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Li Y; Song X; Zhao X; Zou L; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
[TBL] [Abstract][Full Text] [Related]
12. Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis.
Nahon P; Amathieu R; Triba MN; Bouchemal N; Nault JC; Ziol M; Seror O; Dhonneur G; Trinchet JC; Beaugrand M; Le Moyec L
Clin Cancer Res; 2012 Dec; 18(24):6714-22. PubMed ID: 23136190
[TBL] [Abstract][Full Text] [Related]
13. Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry.
Cao H; Huang H; Xu W; Chen D; Yu J; Li J; Li L
Anal Chim Acta; 2011 Apr; 691(1-2):68-75. PubMed ID: 21458633
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma.
Chun JM; Kwon HJ; Sohn J; Kim SG; Park JY; Bae HI; Yun YK; Hwang YJ
J Surg Oncol; 2011 Feb; 103(2):148-51. PubMed ID: 21259248
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics study of hepatocellular carcinoma: discovery and validation of serum potential biomarkers by using capillary electrophoresis-mass spectrometry.
Zeng J; Yin P; Tan Y; Dong L; Hu C; Huang Q; Lu X; Wang H; Xu G
J Proteome Res; 2014 Jul; 13(7):3420-31. PubMed ID: 24853826
[TBL] [Abstract][Full Text] [Related]
16. Half-life of serum alpha-fetoprotein: an early prognostic index of recurrence and survival after hepatic resection for hepatocellular carcinoma.
Shim JH; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Chung YH; Lee YS; Lee HC
Ann Surg; 2013 Apr; 257(4):708-17. PubMed ID: 23108121
[TBL] [Abstract][Full Text] [Related]
17. Glutathione species and metabolomic prints in subjects with liver disease as biological markers for the detection of hepatocellular carcinoma.
Sanabria JR; Kombu RS; Zhang GF; Sandlers Y; Ai J; Ibarra RA; Abbas R; Goyal K; Brunengraber H
HPB (Oxford); 2016 Dec; 18(12):979-990. PubMed ID: 28340971
[TBL] [Abstract][Full Text] [Related]
18. Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection.
Yao WJ; Wang ST; Chow NH; Chang TT; Lin PW; Tu DG
Cancer; 2002 Jul; 95(1):112-8. PubMed ID: 12115324
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice.
Li S; Liu H; Jin Y; Lin S; Cai Z; Jiang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(24):2369-75. PubMed ID: 21763219
[TBL] [Abstract][Full Text] [Related]
20. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling.
Patterson AD; Maurhofer O; Beyoglu D; Lanz C; Krausz KW; Pabst T; Gonzalez FJ; Dufour JF; Idle JR
Cancer Res; 2011 Nov; 71(21):6590-600. PubMed ID: 21900402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
